Catalyst Wire Dossier Catalyst Wire Dossier

KH-1

· Kalin Health, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KH-1, covering 2024-06-06 to 2024-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of KH-1 for Stimulating Autophagy in Non-diabetic Adults With Elevated Blood Glucose Concentration [NA]

See pricing